Production (Stage)
TG Therapeutics, Inc.
TGTX
$34.57
$0.330.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.15M | 23.38M | -14.36M | 95.69M | 41.20M |
| Total Depreciation and Amortization | 47.00K | 68.00K | 97.00K | 159.00K | 172.00K |
| Total Amortization of Deferred Charges | 1.87M | 2.21M | 2.54M | 2.77M | 2.77M |
| Total Other Non-Cash Items | 49.68M | 43.12M | 40.25M | 34.10M | 38.55M |
| Change in Net Operating Assets | -151.77M | -109.30M | -56.61M | -64.89M | -62.40M |
| Cash from Operations | -61.03M | -40.52M | -28.09M | 67.82M | 20.28M |
| Capital Expenditure | -70.00K | -45.00K | -24.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.65M | -991.00K | -61.56M | -82.47M | -53.74M |
| Cash from Investing | -4.72M | -1.04M | -61.58M | -82.47M | -53.74M |
| Total Debt Issued | 244.82M | 244.82M | 244.82M | 0.00 | 0.00 |
| Total Debt Repaid | -107.55M | -107.55M | -107.55M | -- | -- |
| Issuance of Common Stock | 925.00K | 914.00K | 344.00K | 566.00K | 47.48M |
| Repurchase of Common Stock | -14.88M | -8.76M | -2.15M | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -889.00K | -889.00K | -858.00K | 0.00 | 0.00 |
| Cash from Financing | 122.42M | 128.53M | 134.60M | 565.00K | 47.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.68M | 86.97M | 44.93M | -14.09M | 14.02M |